Fig. 2
Influence of frailty on 2053 general practitioners (GPs) when deciding to start antihypertensive treatment per country (adjusteda). aAdjusted for GP characteristics (gender, experience, location, prevalence of oldest-old, guideline compliance) and patient characteristics (cardiovascular disease, systolic blood pressure). A mixed-effects model was used to account for multiple assessments per GP. Although 2543 GPs participated, missing data on GPs’ decisions to treat the eight cases means that only 2053 GPs are included here